Tuberculosis Due to High-Dose Challenge in Partially Immune Individuals: A Problem for Vaccination?

Rook, Graham A. W.; Hernández-Pando, Rogelio; Zumla, Alimuddin
March 2009
Journal of Infectious Diseases;3/1/2009, Vol. 199 Issue 5, p613
Academic Journal
The currently available vaccine for tuberculosis (TB) is ineffective in developing countries. We need to understand the pathogenesis of TB in those countries and how it differs from the pathogenesis of TB in wealthy countries, to facilitate the design and interpretation of clinical trials of new vaccine candidates that are now available. We show here that these geographical differences parallel the strikingly different immunology and bacterial growth curves seen in animal models after high-dose and low-dose challenge with M. tuberculosis (Mtb). We consider this point in the light of recent insights into the multiple pathways used by the immune response to control M. tuberculosis and the susceptibilities of these pathways to regulation and suppression. There are important implications for the screening, testing, and likely success of vaccine candidates.


Related Articles

  • Immune mechanisms of protection: can adjuvants rise to the challenge? McKee, Amy S.; MacLeod, Megan K. L.; Kappler, John W.; Marrack, Philippa // BMC Biology;2010, Vol. 8, p37 

    For many diseases vaccines are lacking or only partly effective. Research on protective immunity and adjuvants that generate vigorous immune responses may help generate effective vaccines against such pathogens.

  • PREFACE [Hot topic: Molecules of Infectious Agents as Immunomodulatory Drugs (Guest Editor: William Harnett)]. Harnett, William // Current Topics in Medicinal Chemistry;Feb2004, Vol. 4 Issue 5, p1 

    Molecules of Infectious Agents as Immunomodulatory Drugs The continuous need to control infectious agents has invariably led to the application of emerging new biological disciplines and / or methodologies to their study. Particularly pertinent, advances in immunology and molecular biology...

  • Immunology of vaccination. Beverley, P. C. L. // British Medical Bulletin;Jul2002, Vol. 62 Issue 1, p15 

    An ideal vaccine is relatively easy to define, but few real vaccines approach the ideal and no vaccines exist for many organisms, for which a vaccine is the only realistic protective strategy in the foreseeable future. Many difficulties account for the failure to produce these vaccines. All...

  • The Development of an AIDS Mucosal Vaccine. Xian Tang; Zhiwei Chen // Viruses (1999-4915);Jan2010, Vol. 2 Issue 1, p283 

    It is well known that mucosal tissues contain the largest surface area of the human body and are the front line of natural host defense against various pathogens. In fact, more than 80% of infectious disease pathogens probably gain entry into the susceptible human hosts through open mucosal...

  • From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease. Mortellaro, Alessandra; Ricciardi-Castagnoli, Paola // Immunology & Cell Biology;Mar2011, Vol. 89 Issue 3, p332 

    Over the past 50 years, the practice of vaccination has reached the important goal of reducing many of the diseases that afflicted humanity in past centuries. A better understanding of immunological mechanisms underlying the induction of immune protection and the advent of new technology led to...

  • Intranasal immunization with AFCo1 induce systemic, mucosal and memory immune response in neonatal mice. Balboa, Julio A.; Romeu, Belkis; Cuello, Maribel; Zayas, Caridad; Del Campo, Judith; González, Elizabeth; Acevedo, Reynaldo; Lastre, Miriam; Cabrera, Osmir; Pérez, Oliver // Revista VacciMonitor (Vacunología y Temas Afines);May-Aug2009, Vol. 18 Issue 2, p79 

    Neonates have a poorly developed immune system. Respiratory pathogens cause disease during early periods of live. Consequently, it is important to develop protective vaccines that induce immunity and immunological memory against respiratory pathogens early in life. Intranasal (i.n.) route could...

  • CD40Ab adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis. Bhagawati-Prasad, Vijay N. S.; De Leenheer, Evy; Keefe, Nadine P.; Ryan, Lorna A.; Carlring, Jennifer; Heath, Andrew W. // Journal of Immune Based Therapies & Vaccines;2010, Vol. 8, p1 

    Active vaccination can be effective as a post-exposure prophylaxis, but the rapidity of the immune response induced, relative to the incubation time of the pathogen, is critical. We show here that CD40mAb conjugated to antigen induces a more rapid specific antibody response than currently used...

  • Targeting multiple pathways improves vaccine efficacy.  // Journal of Clinical Investigation;May2011, Vol. 121 Issue 5, p1669 

    The article reports that connecting molecules that activate immune responses via different innate signaling pathways to the vaccine antigen is a critical step for optimizing protective immunity.

  • New TB vaccine surpasses BCG.  // GP: General Practitioner;9/9/2011, p9 

    The article reports on researchers from the Albert Einstein College of Medicine in New York triggering a greater immune response to the bacteria in mice that could lead to a more effective tuberculosis vaccine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics